Presentation TCT 2023 SYMAP Clinical Trial Program (Radio-Frequency Renal Denervation) Presenter: Felix Mahfoud October 25, 2023
Presentation TCT 2023 SPYRAL Clinical Trial Program (Radio-Frequency Renal Denervation) Presenter: David Kandzari October 25, 2023
Presentation TCT 2023 RADIANCE Clinical Trial Program (Ultrasound Renal Denervation) Presenter: Ajay Kirtane October 25, 2023
Presentation TCT 2023 Preclinical Science In Renal Denervation – What Is New, What Is Clinically Relevant? Presenter: Lucas Lauder October 25, 2023
Presentation TCT 2023 Long-term Management of DVTs for the Interventional Cardiologist Presenter: Teresa Carman October 25, 2023
News Conference News TCT 2023 LIFE-BTK: Bioresorbable Scaffold Holds Promise for Infrapopliteal CLTI L.A. McKeown October 25, 2023
News Conference News TCT 2023 Paclitaxel Safety Questions in PAD: Will ‘Capstone’ Data Close the Door? L.A. McKeown October 24, 2023
Presentation TCT 2023 TCT 558: Clinical Outcome and Mortality of Catheter-interventional Treatment Options in high-risk Pulmonary Artery Embolism Presenter: Luise Mentzel October 24, 2023
News Daily News Radial Access Is Safe, Effective for Peripheral Interventions: R2P Registry Todd Neale October 16, 2023
News Daily News AHA Scientific Statement Urges Incorporation of Mental Health Care in PAD L.A. McKeown October 06, 2023
News Daily News Cardiology Society Leaders Expand on Vision for New Medical Board Todd Neale October 05, 2023
News Daily News Medtronic’s Renal Denervation System Fails to Sway FDA Advisory Panel L.A. McKeown August 23, 2023
News Daily News As Renal Denervation Heads to Advisory Review, FDA Sets Out Key Questions L.A. McKeown August 18, 2023
News Opinion Editor's Corner ESC 2023 What’s Going to Be Hot at ESC 2023? Shelley Wood August 15, 2023
News Daily News CMS Issues Proposed Coverage Decision to Broaden Access for Carotid Stenting L.A. McKeown July 12, 2023
News Daily News FDA: All Restrictions on Paclitaxel Devices for PAD Are Removed L.A. McKeown July 11, 2023
News Conference News LINC 2023 PROSPECT MONSTER: Real-World Data Confirm Low-Dose DCB Efficacy in PAD L.A. McKeown June 21, 2023